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Deep venous thrombosisAbstract Pulmonary embolism (PE) is a life-threatening condition or complication and might be
one of the worst nightmares for most surgeons.
The aim of this study was to evaluate the incidence of venous thrombo-embolism (VTE) in
patients undergoing major abdominal surgery and major orthopedic surgery who received VTE
prophylaxis.
Methods: Between January of 2010 and September of 2013 all the patients who underwent major
abdominal surgery and major orthopedic surgery who received VTE prophylaxis, at King Fahad
Hospital Dammam Kingdom of Saudi Arabia, were prospectively evaluated for the incidence of
DVT and PE within 30 postoperative days.
Results: The incidence of symptomatic DVT and PE in the patients studied was 2.23% and
2.03%, respectively. The incidences of PE and DVT following abdominal surgery were 2.44%,
and the incidences of PE and DVT following orthopedic surgery were 1.62% and 2.03%, respec-
tively.
Conclusion: Despite the use of thromboprophylaxis, PE and DVT were important complications
of major abdominal and major orthopedic surgery.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Introduction
Pulmonary embolism (PE) is a life-threatening condition or
complication and might be one of the worst nightmares formost surgeons. The embolus that causes the obstruction usu-
ally travels through the venous system from a distant site.
PE causes symptoms such as dyspnea, chest pain or collapse.
Moreover, the clinical severity of PE can vary, ranging from
asymptomatic cases to sudden death. Despite advances in diag-
nosis and treatment, PE remains a signiﬁcant cause of morbid-
ity and mortality and is still one of the most common
preventable causes of death, which is easily overlooked [1,2].
Risk factors for deep vein thrombosis (DVT) and PE are priord.
250 A. Attia et al.medical history of DVT or PE, recent surgery, general anesthe-
sia lasting longer than 30 min, pregnancy, prolonged immobi-
lization, age >40 years, obesity or underlying malignancy
[3,4]. Moreover, gynecologic surgery, major trauma and
indwelling venous catheters are risk factors for DVT at any
location. Otherwise, venous thrombosis commonly involves
lower limbs, affecting most frequently calf veins, which are
involved in virtually 100% of symptomatic, spontaneous lower
extremity DVT. Although DVT usually starts in calf veins, it is
propagated above the knee in 87% of symptomatic patients
before the diagnosis has been made. However, more than
35% of patients who die from PE may have isolated calf vein
thrombosis [5]. Because perioperative VTE is asymptomatic in
the majority of the cases (95%), this important clinical condi-
tion might be underestimated by surgeons, resulting in inade-
quate use of prophylactic anticoagulants [6].
The aim of this study was to evaluate the incidence of
venous thromboembolism (VTE) in patients undergoing major
abdominal surgery and major orthopedic surgery who received
VTE prophylaxis.
Methods and subjects
The study was approved by the King Fahad Hospital Ethics
and Research committee. Between January of 2010 and
September of 2013 all the patients who underwent major
abdominal surgery (bariatric surgery, Whipple operation, colo-
rectal surgery, nephrectomy, splenectomy) and major orthopedic
surgery (hip arthroplasty, knee arthroplasty, or femur fracture
repair), were included in the study (Table 1). 493 patients who
had been referred to the Orthopedics and General Surgery
Departments of the King Fahad Hospital Dammam Kingdom
of Saudi Arabia, and submitted to surgery were prospectively
studied and evaluated for the incidence of DVT and PE within
30 postoperative days. The departments had a standard protocol
for thromboprophylaxis (enoxaparin 40 mg/day s.c., and the
use of graded compression stockings). This protocol was used
during the period of the study. Patients who underwent major
abdominal surgery and major orthopedic surgery in the hospi-
tal were routinely followed on postoperative day 14, and 30Table 1 Demographic data, type of surgery, and incidence of PE a
Variable Result
Age 64.46 ± 19.12
Gender
Male 229 (46.45%)
Female 264 (53.55%)
Type of surgery
Abdominal surgery 246 (49.89)
Orthopedic surgery 247 (50.11)
Bariatric surgery 35 (7.10%)
Whipple operation 99 (20.08%)
Colorectal surgery 83 (16.84%)
Splenectomy 6 (1.21%)
Nephrectomy 6 (1.21%)
Knee arthroplasty 94 (19.07%)
Hip arthroplasty 67 (13.59%)
Femur fracture repair 86 (17.44%)
PE: Pulmonary Embolism, DVT: Deep Venous Thrombosis.after had discharged 7 days postoperative. Patients who had
respiratory symptoms (pleuritic chest pain, dyspnea, hemopty-
sis, or cough), with or without signs and symptoms consistent
with DVT (swelling, pain, tenderness, increase in the diameter
of lower limbs, or local heat), were referred and evaluated by a
pulmonologist as a consultation. Patients suspected of having
VTE were submitted to chest CT angiography and Doppler
ultrasound of the lower extremities by an expert radiologist.
Chest CT angiography was performed with a 16-section multi-
detector CT scanner (LightSpeed 16; GE Healthcare, Milwau-
kee, WI, USA) within 24 h. PE was diagnosed when an
intraluminal ﬁlling defect surrounded by intravascular contrast
or total occlusion of the pulmonary arterial lumen was
detected at any level of the pulmonary arteries. Doppler ultra-
sound of the deep veins of the lower extremities was performed
with a standard method using a dedicated ultrasound unit
(LOGIQ 7; GE Healthcare) with a 10 L linear array transducer
(bandwidth, 6–10 MHz) in order to investigate the presence/
absence of intravenous thrombi. Data on the type of surgical
procedure, the type and duration of anesthesia, and other
potential risk factors for VTE, including obesity, immobility
(bed rest >48 h), malignancy, previous history of VTE,
COPD, smoking, congestive heart failure, trauma, thrombocy-
tosis, and history of hormone replacement, were also recorded
(Table 2). In addition, the time of initiation and the duration
of thromboprophylaxis were collected.
Statistical analysis
Data were analyzed using the Statistical Package for the Social
Sciences for Windows, version 16.0 (SPSS Inc., Chicago, IL,
USA). Descriptive statistical analysis results were presented
as absolute and relative frequencies. Differences between
groups for categorical variables were analyzed using the chi-
square test or Fisher’s exact test, where appropriate. The three
clinically important variables among those which were found
signiﬁcantly effective in the development of VTE in the univar-
iate analysis were evaluated by multiple logistic regression
analysis in order to deﬁne independent risk factors of outcome
variables.nd DVT in the patients included in the study.
PE (N= 10) DVT (N= 11)
4 (40%) 4(36.36%)
6 (60%) 7(63.63%)
6 (60%) 6 (54.55%)
4 (40%) 5 (45.45%)
1 (10%) 1 (9.09%)
2 (20%) 2 (18.18%)
3 (30%) 3 (27.27%)
0 0
0 0
0 0
1 (10%) 1 (9.09%)
3 (30%) 4 (36.37%)
Table 2 Distribution of potential risk factors for pulmonary
embolism and DVT.
Risk factors Study sample (n= 493)
Abdominal Surgery 246 (49.89)
Orthopedic surgery 247 (50.11)
Obesity 95 (19.27)
Immobility 145 (29.41)
Malignancy 106 (21.50)
Previous history of VTE 34 (6.09)
COPD 19 (3.85)
Congestive heart failure 39 (7.91)
Smoking 63 (12.78)
Trauma 0
Hormonal replacement 0
Thrombocytosis 0
Thromboprophylaxis does not prevent venous thromboembolism 251Results
Demographic data, type of surgery, and incidence of PE and
DVT in the patients included in the study are shown in Table 1.
The mean age of the patients was 64.46 ± 19.12 years.
Females and males accounted for 229 and 264, respectively.
General anesthesia was administered to 58.9% of the patients,
whereas 41.1% of the patients were treated with combined
spinal-epidural anesthesia. Patients who underwent of bariat-
ric surgery 35 (7.10%), Whipple operation 99 (20.08%), colo-
rectal surgery 83 (16.84%), nephrectomy 23 (4.67%),
splenectomy 6 (1.21%), knee arthroplasty 94 (19.07%), hip
arthroplasty 67 (13.59%), and femur fracture repair 86
(17.44%). Of the 493 patients, 10 (2.03%) and 11 (2.23%),
respectively, were diagnosed with PE and DVT. All of the
patients wore compression stockings and received VTE pro-
phylaxis. Enoxaparin (40 mg/day) was the anticoagulant used
for all of the patients, who received VTE prophylaxis during
30 postoperative days. Prophylaxis was started at the tenth
postoperative hour. Nearly one-half of the patients (48.68%)
presented with one or more than one risk factor for VTE other
than the surgery (immobility and obesity). Additional risk fac-
tors for VTE are included in Table 2.
The incidence of symptomatic DVT and PE in the patients
studied was 2.23% and 2.03%, respectively. All of the patients
with PE were also diagnosed with concomitant DVT. The inci-
dences of PE and DVT following abdominal surgery were
2.44%, and the incidences of PE andDVT following orthopedic
surgery were 1.62%, and 2.03%, respectively. The incidences of
PE and DVT following bariatric, surgery, Whipple operation,Table 3 Time for the onset of pulmonary embolism and deep vein
Onset of PE and DVT postoperative days
1
2
3
4
5
7
14
30
Totaland colorectal surgery were 2.85%, 2.02% and 3.61% respec-
tively, and the incidences of PE following hip arthroplasty,
and femur fracture repair were 1.49% and 3.49%, respectively,
and the incidence of DVT following femur fracture repair was
4.65%. Of the patients who had PE and DVT, 80% and
81.82%, respectively, developed them within the ﬁrst 5 postop-
erative days. The time for the onset of PE and DVT in the
patients is shown in Table 3 (see Fig. 1).
The majority of the patients (78.6%) who developed PE
were aged P65 years (p= 0.004). No signiﬁcant differences
were found regarding the gender or the type of anesthesia
administered in the group of patients who developed PE
(p> 0.05). The multiple logistic regression analysis revealed
that the patients undergoing colorectal surgery and Whipple
operation were at a greater risk for the development of PE
and DVT than those who underwent bariatric surgery,
nephrectomy, splenectomy (OR= 3.338; 95% CI: 1.175–
15.39; p= 0.023) and those who underwent femur fracture
repair were at a greater risk for the development of PE and
DVT than those who underwent knee or hip arthroplasty
(OR = 5.113; 95% CI: 1.161–17.29; p= 0.028). Patients aged
P65 years also had higher rates of PE (OR= 4.856; 95% CI:
1.074–21.953; p= 0.040).
The incidence of PE and DVT was higher in bedridden
patients than in those who were not (p= 0.004). However, the
incidence of PE and DVT in obese patients or in patients with
a previous history of VTE, COPD, congestive heart failure,
trauma, smoking, hormone replacement, or thrombocytosis
was not signiﬁcantly higher than in the other participants
(p> 0.05 for all).Discussion
Venous thromboembolism (VTE), deep vein thrombosis
(DVT) and pulmonary embolism (PE), are important causes
of morbidity and mortality. The risk of VTE is highest in
patients undergoing major surgery [7]. PE is the third most
common cause of death in the US, with at least 650,000 cases
occurring annually. Furthermore, PE represents the ﬁrst or
second most common cause of unexpected death in most age
groups. The highest incidence of recognized PE occurs in hos-
pitalized patients. Autopsy results are showing that up to 60%
of patients who die at a hospital have PE, and that diagnosis is
missed in about 70% of cases [8].
In our study, the incidence of PE and DVT in the patients
following major surgery was 2.03% and 2.23%, respectively.
Most of the patients developed PE or DVT within the ﬁrst 5
postoperative days. The patients undergoing colorectal surgerythrombosis in the study sample.
PE (N= 10) DVT (N= 11)
0 0
4 (40%) 3 (27.27%)
3 (30%) 4 (36.36%)
1 (10%) 2 (18.19%)
0 0
1 (10%) 1 (9.09%)
1 (10%) 1 (9.09%)
0 0
10 (2.03%) 11 (2.23%)
Figure 1 Showed subsegmental pulmonary embolism.
252 A. Attia et al.and femur fracture repair, those aged P65 years, and those
who were bedridden were at a higher risk for developing
VTE. All of the patients undergoing major abdominal surgery
and major orthopedic surgery in the hospital under study
received VTE prophylaxis. The surgery creates an additional
risk for the development of VTE. It has been previously
reported that VTE can develop following colorectal surgery
and hip and femur fracture surgery despite thromboprophylax-
is [9]. The incidence of PE was highest in the patients submitted
to femur fracture repair (3.49%) among the major orthopedic
surgeries in our study population. This can be explained by
the following factors: patients undergoing femur fracture repair
are commonly older, and long bone fracture itself increases the
risk for VTE due to prolonged immobility and increased endo-
thelial injury. It has been previously reported that the low inci-
dence of symptomatic VTE perioperatively (5%) might mislead
surgeons into considering PE as a rare complication of major
orthopedic surgeries [10,11]. On the contrary, the present study
demonstrated that approximately 80% of symptomatic PE
occurred within the ﬁrst 5 postoperative days, despite the rou-
tine use of prophylaxis. It is well known that damage to vascu-
lar endothelium and venous stasis resulting in endothelial
hypoxia can cause the activation of the coagulation cascade.
The natural ﬁbrinolytic activity of the body tries to overcome
the formation of thrombosis. The development of PE, more
commonly within 5 days after surgery, might be due to the early
intense effect of endothelial injury and hypoxia because of the
surgical trauma and venous stasis [12].
In one study, the incidence of PE in patients who did not
receive prophylaxis was approximately 50% [11]. The use of
prophylaxis decreased the incidence but did not completely
resolve the problem. In one meta-analysis, it was reported that
the incidence of PE within 3 months after the procedure was
3.2% in patients receiving short-term prophylaxis (7–10 days)
[13]. The incidence of PE was lower in the present study than
in that meta-analysis. This difference between the results might
be explained by the long-term prophylaxis (30 days) and the
short duration of the follow-up of the patients (30 postoperative
days) in our study, in contrast to the results in the studies
included in that meta-analysis. Previous studies showed that
the duration of prophylaxis reduced the risk of symptomatic
DVT [14,15]. However, despite the long-term use of thrombo-
prophylaxis in our study population, the prevention of thisimportant complication was not completely achieved. Enoxap-
arin was the anticoagulant therapy administered to the high-risk
population for prophylaxis. The commonly used dose of the
medication was 40 mg/day (4000 IU) in all of the patients
despite their weight. The recommended dose of LMWH for
thromboprophylaxis is>3400 IU in accordancewith theACCP
guidelines, althoughweight-based dose adjustments of LMWHs
might provide more effective prophylaxis. ACCP recommends
long-term thromboprophylaxis (30–35 days) after major sur-
gery [16]. When we reviewed the LMWH dose in the protocol,
we realized that the dose was consistent with the ACCP guide-
lines. In our study, the risk of PE and DVT was also higher in
patients undergoing surgery for colorectal surgery (3.61%) as
compared to those having other abdominal surgery. The
increased risk of PE and DVT can be explained by a number
of factors, such as malignancy-related hypercoagulable state,
postoperative infectious complications, prolonged surgery, and
pelvic dissection [17]. An increased risk of PE after colorectal
surgery has also been showed by Lee et al. in a study on Chinese
patients who underwent colorectal surgery without DVT
prophylaxis. The authors demonstrated the occurrence of
asymptomatic calf vein thrombosis in 41.7% of patients using
serial Duplex ultrasound studies [18]. Kerkez et al. [19] reported
that, the incidence of PE after colorectal surgery of patients who
received prophylaxis was signiﬁcantly lower compared to that
seen among subjects with colorectal surgery without prophy-
laxis. White et al. reported that the incidence of VTE after hip
arthroplasty was higher than that of VTE after knee arthro-
plasty (2.8% vs. 2.1%) [20]. Our study showed a more striking
difference between the incidence of PE following hip and knee
arthroplasty (1.49% vs. 0%). Similarly to previous data
[21,22], the highest incidence of PE in the present study
(3.49%) occurred in the patients who underwent femur fracture
repair. Shorr et al. found the incidence of PE after major ortho-
pedic surgery in patients receiving enoxaparin to be 2.3% [23].
Although the frequency of PE increases with age, this is not
an independent risk factor. Nevertheless, the accumulation of
different risk factors, such as underlying illnesses and decreased
mobility, increases the frequency of PE in older patients. Unfor-
tunately, diagnosis of PE is often missed, especially in older
patients. PE is diagnosed in 30% of all patients who die with
massive PE, but only in 10% of those who are 70 years of age
or older. Thus, PE still remains the most commonly missed
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study, we found that, patients agedP65 years were at a signif-
icantly higher risk for PE after major surgery. Additional risk
factors other than surgery, such as malignancy and immobility,
might increase with age. It is known that patients aged
>40 years are at a greater risk for VTE than younger patients
and that prolonged immobility, together with other major risk
factors, increases the risk for VTE. Although a previous history
showed VTE and obesity to be known risk factors for VTE [11],
these two conditions were not found to be independent risk fac-
tors for VTE in the present study. In our study, the previous his-
tory of VTE of patients might not have been adequately
documented on the medical records. Bleeding as a complication
frommedical prophylaxis is one of the factors that might lead to
its inadequate use by the surgeons, especially following proce-
dures such as a major orthopedic surgery. However, previous
studies showed that the risk of clinically signiﬁcant bleeding
did not increase with medical prophylaxis [25]. In our
study, patients who received prophylaxis with low dose LMWH
after major surgery did not have any side effects (such as
bleeding).Conclusion
Despite the use of thromboprophylaxis, PE and DVT were
important complications of major abdominal and major
orthopedic surgery.Contribution
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